FIELD: medicine, veterinary science.
SUBSTANCE: invention concerns veterinary. The pharmaceutical composition for treating diabetes containing tripeptide Pro-Gly-Pro as an agent dissolved in such proportion that the amount of the intranasal tripeptide is 1 mg/kg of body weight. The method of treating diabetes involves the intranasal introduction of the described composition.
EFFECT: invention allows faster recovery, lower toxic effects without deterioration of clinical effectiveness, and simplified introduction procedure.
2 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING DIABETES IN MAMMALS AND INTRANASAL PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES IN MAMMALS | 2009 |
|
RU2403909C1 |
APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
USING TETRAPEPTIDE Pro-Gly-Pro-Val AS AGENT FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, METHOD FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LIPID STORAGE DISEASE AND METHOD FOR PREPARING IT | 2013 |
|
RU2537133C2 |
USING TETRAPEPTIDE Arg-Pro-Gly-Pro AS AGENT FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, METHOD FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA AND METHOD FOR PREPARING IT | 2013 |
|
RU2538801C2 |
AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
PEPTIDE POSSESSING ANTICOAGULANT, FIBRIN-DEPOLYMERIZING, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2289423C1 |
ANTI-THROMBOSIS, ANTI-COAGULATING, FIFRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT FOR INTRANASAL ADMINISTRATION | 2005 |
|
RU2290193C1 |
APPLICATION OF PRO-GLY-PRO TRIPEPTIDE AS PREPARATION FOR TREATING AND PREVENTING DIABETES, METHOD FOR PREVENTING AND TREATING DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DIABETES | 2004 |
|
RU2252778C1 |
PEPTIDE POSSESSING ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2288736C1 |
ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
Authors
Dates
2010-11-20—Published
2009-10-23—Filed